Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in South Africa, has entered into an agreement with Rene Glyne Family trust to sell and dispose of the entire 24.5% shares held by Aurogen. After the disposal of 24.5% shares held by Aurogen, Aurogen will cease to be the joint venture partner of Novagen BBBEE Invest Co (Proprietary).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
